Related Experiment Video
Updated: May 17, 2026
10:55
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Evaluation and management of polymyositis
1RNP Veterans Health, Rheumatology and Hematology, Rheumatology Section, VA Palo Alto Health Care System, Stanford University School of Medicine, USA.
Indian Journal of Dermatology
|November 1, 2012
Summary
Polymyositis (PM) is an autoimmune disorder causing muscle inflammation and weakness, primarily affecting proximal muscles. Treatment with corticosteroids and immunosuppressants improves function, with a 95% 5-year survival rate.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Background:
- Polymyositis (PM) is an idiopathic inflammatory myopathy characterized by inflammatory infiltrates in skeletal muscle.
- The primary clinical feature of PM is proximal muscle weakness, with an unknown autoimmune etiology.
- PM typically affects individuals aged 50-70, is more prevalent in females and Black individuals, with an overall prevalence of 1 in 100,000.
Purpose of the Study:
- To describe the clinical manifestations, associations, and treatment outcomes of Polymyositis.
- To highlight the diagnostic and therapeutic challenges in managing this autoimmune muscle disease.
Main Methods:
- Literature review of Polymyositis (PM) and related inflammatory myopathies.
- Analysis of clinical presentation, diagnostic criteria, and therapeutic strategies for PM.
Main Results:
- PM presents with proximal muscle weakness, potentially leading to dysphagia, ventilatory compromise, and cardiac issues.
- Associated conditions include malignancies and other rheumatic diseases; drug- or virus-induced myopathies are also noted.
- Corticosteroids and immunosuppressants are primary treatments, aiming to improve strength and function.
Conclusions:
- Polymyositis is a serious autoimmune condition requiring long-term management.
- Therapeutic interventions significantly improve patient outcomes, with a high 5-year survival rate.
- Residual muscle weakness may persist in a portion of treated patients.
Related Concept Videos
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...